Department of Psychiatry, and National Clinical Research Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China.
Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China.
J Affect Disord. 2023 Jun 15;331:82-91. doi: 10.1016/j.jad.2023.03.047. Epub 2023 Mar 21.
This study aimed to identify common and exclusive neural substrates underlying pure generalized anxiety disorder (GAD, G0) and comorbid GAD and depression (G1), assess whether they could assist in diagnosis and prediction of treatment response, and determine whether comorbid depression in GAD patients would change their neural plasticity.
A longitudinal study was conducted, involving 98 patients (40 in the G0 group and 58 in the G1 group) and 54 healthy controls (HCs). The fractional amplitude of low-frequency fluctuations (fALFF), support vector machine, and support vector regression were employed.
The shared neural underpinnings across the two subtypes of GAD were hyperactivity in the right cerebellar Crus II and inferior temporal gyrus and hypoactivity in the right postcentral gyrus. The G1 group showed hypoactivity in the frontal gyrus, compared with HCs, and hyperactivity in the middle temporal gyrus, compared with the G0 group or HCs. These alterations could aid in diagnosis and the prediction of treatment response with high accuracy. After treatment, both the G1 and G0 groups showed higher fALFF than those before treatment but were located in different brain regions.
The study was performed in a single center and subjects showed a fairly homogeneous ethnicity.
Common and exclusive neural substrates underlying the two subtypes of GAD were identified, which could assist in diagnosis and the prediction of treatment response. Pharmacotherapy for the two subtypes of GAD recruited different pathways, suggesting that comorbid depression in GAD patients would change their neural plasticity.
本研究旨在确定单纯广泛性焦虑障碍(GAD,G0)和共病 GAD 和抑郁(G1)的共同和独特的神经基础,评估它们是否有助于诊断和预测治疗反应,并确定 GAD 患者共病抑郁是否会改变其神经可塑性。
进行了一项纵向研究,涉及 98 名患者(G0 组 40 名,G1 组 58 名)和 54 名健康对照者(HCs)。采用分数低频波动(fALFF)、支持向量机和支持向量回归。
两种 GAD 亚型共有的神经基础是右侧小脑 Crus II 和下颞叶的过度活跃,以及右侧后中央回的活动减少。与 HCs 相比,G1 组的额回活动减少,与 G0 组或 HCs 相比,中颞叶活动增加。这些改变可以帮助进行高准确率的诊断和治疗反应预测。治疗后,G1 组和 G0 组的 fALFF 均高于治疗前,但位于不同的脑区。
该研究在单中心进行,研究对象具有相当同质的种族。
确定了两种 GAD 亚型的共同和独特的神经基础,有助于诊断和预测治疗反应。两种 GAD 亚型的药物治疗募集了不同的途径,这表明 GAD 患者共病抑郁会改变其神经可塑性。